861
Views
11
CrossRef citations to date
0
Altmetric
Pharmacology

Healthcare resource use and cost associated with varying dosages of extended corticosteroid exposure in a US population

, , , , , , & show all
Pages 846-852 | Received 30 Mar 2018, Accepted 03 May 2018, Published online: 23 May 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jas Bindra, Ishveen Chopra, Kyle Hayes, John Niewoehner, Mary Panaccio & George J Wan. (2023) Cost-Effectiveness of Acthar Gel versus Standard of Care for the Treatment of Advanced Symptomatic Sarcoidosis. ClinicoEconomics and Outcomes Research 15, pages 739-752.
Read now
Laura Bartels-Peculis, Ajay Sharma, Alison M Edwards, Anirudh Sanyal, Erin Connolly-Strong & Winnie W Nelson. (2020) Treatment Patterns and Health Care Costs of Lupus Nephritis in a United States Payer Population. Open Access Rheumatology: Research and Reviews 12, pages 117-124.
Read now
J. Bradford Rice, Alan G. White, Michaela Johnson, Aneesha Wagh, Yimin Qin, Laura Bartels-Peculis, Gosia Ciepielewska & Winnie W. Nelson. (2018) Quantitative characterization of the relationship between levels of extended corticosteroid use and related adverse events in a US population. Current Medical Research and Opinion 34:8, pages 1519-1527.
Read now

Articles from other publishers (8)

Kyle Hayes, John Niewoehner, J. Bradford Rice, Nathaniel Downes, Ella Hagopian, Izzy Ma & George J. Wan. (2023) Corticosteroid Use and Adherence in Patients Treated with Acthar Gel for Advanced Sarcoidosis. Advances in Therapy.
Crossref
Jas Bindra, Ishveen Chopra, Kyle Hayes, John Niewoehner, Mary P. Panaccio & George J. Wan. (2022) Understanding Predictors of Response to Repository Corticotropin Injection Treatment Among Patients With Advanced Symptomatic Sarcoidosis. Journal of Health Economics and Outcomes Research 9:1, pages 90-100.
Crossref
Mehdi Mirsaeidi & Robert P. Baughman. (2022) Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis: A Narrative Review. Pulmonary Therapy 8:1, pages 43-55.
Crossref
J. Bradford Rice, Mary P. Panaccio, Alan White, Mark Simes, Emma Billmyer, Nathaniel Downes, John Niewoehner & George J. Wan. (2020) Consequences of Insurance Denials Among U.S. Patients Prescribed Repository Corticotropin Injection for Acute Exacerbations of Multiple Sclerosis. Neurology and Therapy 10:1, pages 149-167.
Crossref
Kyle Hayes, Mary P. Panaccio, Niti Goel & Mohammed Fahim. (2021) Patient Characteristics and Indicators of Treatment Initiation with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis: A Claims Database Analysis. Rheumatology and Therapy 8:1, pages 327-346.
Crossref
Neil M. SchultzDavid F. PensonSamuel D. WilsonYan SongHongbo YangKrishnan RamaswamyBenjamin Lowentritt. (2019) Health Care Resource Utilization and Costs Associated with Corticosteroid Use in Patients with Castration-Resistant Prostate Cancer: An Administrative Claims Analysis. Journal of Managed Care & Specialty Pharmacy 25:8, pages 889-897.
Crossref
Ishveen Chopra, Yimin Qin, John Kranyak, Jack R. Gallagher, Kylee Heap, Susan Carroll & George J. Wan. (2019) Repository corticotropin injection in patients with advanced symptomatic sarcoidosis: retrospective analysis of medical records. Therapeutic Advances in Respiratory Disease 13, pages 175346661988812.
Crossref
Eric P. Hoffman. 2020. Pediatric Pharmacotherapy. Pediatric Pharmacotherapy 25 37 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.